Is there a genetic anticipation in breast and/or ovarian cancer families with the germline c.3481_3491del11 mutation?

about

Is there a genetic anticipation in breast and/or ovarian cancer families with the germline c.3481_3491del11 mutation?

Item

http://www.wikidata.org/entity/Q38685296

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Is there a genetic anticipatio ...... ine c.3481_3491del11 mutation?

@en

type

Item

label

Is there a genetic anticipatio ...... ine c.3481_3491del11 mutation?

@en

prefLabel

Is there a genetic anticipatio ...... ine c.3481_3491del11 mutation?

@en

P1476

Is there a genetic anticipatio ...... ine c.3481_3491del11 mutation?

@en

P2093

E Albuisson

http://www.w3.org/2001/XMLSchema#string

E Luporsi

http://www.w3.org/2001/XMLSchema#string

P Jonveaux

http://www.w3.org/2001/XMLSchema#string

R El Tannouri

http://www.w3.org/2001/XMLSchema#string

P2860

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

Cancer susceptibility and the functions of BRCA1 and BRCA2

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

Adjuvant trastuzumab in the treatment of her-2-positive early breast cancer: a meta-analysis of published randomized trials.

The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit.

Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis.

Genetic anticipation is associated with telomere shortening in hereditary breast cancer.

An investigation of the apparent breast cancer epidemic in France: screening and incidence trends in birth cohorts.

BRCA1 testing in breast and/or ovarian cancer families from northeastern France identifies two common mutations with a founder effect.

P2888

s10689-017-9999-4

P31

scholarly article

P356

10.1007/S10689-017-9999-4

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085384820

http://www.w3.org/2001/XMLSchema#string

P698

28493033

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer